Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Swapnil Rajpathak

Showing results (31-40 of 71) with videos related to

Pageof 8
Sort By:
Current Medical Research and Opinion|March 2, 2021
Comorbidities in type 2 diabetes patients with and without atherosclerotic cardiovascular disease: a retrospective database analysisKristy Iglay, Hakima Hannachi, Samuel S Engel, et al.
The Diabetes Educator|August 23, 2017
Impact of Timely Treatment Intensification on Glycemic Goal Achievement in Patients With Type 2 Diabetes Failing Metformin MonotherapyRohan Mahabaleshwarkar, Megan Templin, Frank Gohs, et al.
Pharmacoeconomics|November 5, 2020
Budget Impact of Oral Semaglutide Intensification versus Sitagliptin among US Patients with Type 2 Diabetes Mellitus Uncontrolled with MetforminElizabeth Wehler, Dominik Lautsch, Stacey Kowal, et al.
Endocrinology, Diabetes & Metabolism|January 11, 2020
Dose distribution and up-titration patterns of metformin monotherapy in patients with type 2 diabetesKristy Iglay, Baanie Sawhney, Alex Z Fu, et al.
JAMA Network Open|November 2, 2019
Association Between Switching to a High-Deductible Health Plan and Discontinuation of Type 2 Diabetes TreatmentA Mark Fendrick, Jason D Buxbaum, Yuexin Tang, et al.
BMJ Open Diabetes Research & Care|February 1, 2022
Real-world weight change, adherence, and discontinuation among patients with type 2 diabetes initiating glucagon-like peptide-1 receptor agonists in the UKTracey Weiss, Lingfeng Yang, Richard D Carr, et al.
Patient Preference and Adherence|December 4, 2020
Real-World Adherence and Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists Therapy in Type 2 Diabetes Mellitus Patients in the United StatesTracey Weiss, Richard D Carr, Sampriti Pal, et al.
Frontiers in Endocrinology|August 28, 2023
Impact of dipeptidyl peptidase-4 inhibitors on glucose-dependent insulinotropic polypeptide in type 2 diabetes mellitus: a systematic review and meta-analysisShangyu Chai, Ruya Zhang, Richard David Carr, et al.
The American Journal of Clinical Nutrition|March 9, 2006
Changes in caffeine intake and long-term weight change in men and womenEsther Lopez-Garcia, Rob M van Dam, Swapnil Rajpathak, et al.
The Journal of Pediatrics|June 8, 2011
Screening for sleep-disordered breathing and excessive daytime sleepiness in adolescent girls with polycystic ovarian syndromeKiran Nandalike, Temima Strauss, Chhavi Agarwal, et al.
Pageof 8

Showing results (31-40 of 71) with videos related to

Sort By:
Pageof 8
Current Medical Research and Opinion|March 2, 2021
Comorbidities in type 2 diabetes patients with and without atherosclerotic cardiovascular disease: a retrospective database analysisKristy Iglay, Hakima Hannachi, Samuel S Engel, et al.
The Diabetes Educator|August 23, 2017
Impact of Timely Treatment Intensification on Glycemic Goal Achievement in Patients With Type 2 Diabetes Failing Metformin MonotherapyRohan Mahabaleshwarkar, Megan Templin, Frank Gohs, et al.
Pharmacoeconomics|November 5, 2020
Budget Impact of Oral Semaglutide Intensification versus Sitagliptin among US Patients with Type 2 Diabetes Mellitus Uncontrolled with MetforminElizabeth Wehler, Dominik Lautsch, Stacey Kowal, et al.
Endocrinology, Diabetes & Metabolism|January 11, 2020
Dose distribution and up-titration patterns of metformin monotherapy in patients with type 2 diabetesKristy Iglay, Baanie Sawhney, Alex Z Fu, et al.
JAMA Network Open|November 2, 2019
Association Between Switching to a High-Deductible Health Plan and Discontinuation of Type 2 Diabetes TreatmentA Mark Fendrick, Jason D Buxbaum, Yuexin Tang, et al.
BMJ Open Diabetes Research & Care|February 1, 2022
Real-world weight change, adherence, and discontinuation among patients with type 2 diabetes initiating glucagon-like peptide-1 receptor agonists in the UKTracey Weiss, Lingfeng Yang, Richard D Carr, et al.
Patient Preference and Adherence|December 4, 2020
Real-World Adherence and Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists Therapy in Type 2 Diabetes Mellitus Patients in the United StatesTracey Weiss, Richard D Carr, Sampriti Pal, et al.
Frontiers in Endocrinology|August 28, 2023
Impact of dipeptidyl peptidase-4 inhibitors on glucose-dependent insulinotropic polypeptide in type 2 diabetes mellitus: a systematic review and meta-analysisShangyu Chai, Ruya Zhang, Richard David Carr, et al.
The American Journal of Clinical Nutrition|March 9, 2006
Changes in caffeine intake and long-term weight change in men and womenEsther Lopez-Garcia, Rob M van Dam, Swapnil Rajpathak, et al.
The Journal of Pediatrics|June 8, 2011
Screening for sleep-disordered breathing and excessive daytime sleepiness in adolescent girls with polycystic ovarian syndromeKiran Nandalike, Temima Strauss, Chhavi Agarwal, et al.
Pageof 8